NetworkNewsBreaks – Brain Scientific Inc.’s (B
Post# of 129
Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has solved issues related to offering neurological services during COVID. The new surge in the Delta variant highlights two problems in hospitals and the neurological market: staff shortages and contamination. “When it comes to neurological services during COVID, Brain Scientific has solved these issues with its two FDA-cleared EEG technologies — the NeuroCap and NeuroEEG. Easy to administer and disposable (the NeuroCap), these low-cost devices allow staff to provide EEGs at the patient’s bedside,” reads a recent article. Brain Scientific’s NeuroCap is disposable, and both devices take five minutes to set up rather than the 30 to 45 minutes it takes to fit a traditional EEG, thus reducing contamination risk. Researchers can also administer the devices because it is not necessary to have medical training to fit the cap. “Data can be collected for more extended periods as the device is portable and worn for up to four hours. The process is also much simpler for the test subject.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer